01 10Intuniv
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 114
2018 Revenue in Millions : 0
Growth (%) : N/A
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 79
2018 Revenue in Millions : 43
Growth (%) : 85
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 176
2019 Revenue in Millions : 117
Growth (%) : 50
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 125
2019 Revenue in Millions : 81
Growth (%) : 55
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 153
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 132
2020 Revenue in Millions : 120
Growth (%) : 18
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 0
2020 Revenue in Millions : 168
Growth (%) : -100
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 146
2021 Revenue in Millions : 132
Growth (%) : 11
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 177
2021 Revenue in Millions : 153
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 171
2022 Revenue in Millions : 177
Growth (%) : 9
LOOKING FOR A SUPPLIER?